Career Enhancement Program

项目摘要 马约诊所乳腺癌SPORE的职业提升计划（CEP）致力于识别 指导最有潜力开发翻译独立项目的初级教师 乳腺癌研究。这是通过严格的审查过程来实现的，目的是确定 有才华和有前途的候选人，其次是密集，严格和有效的指导计划。的 指导计划是建立在多学科指导的建立和最佳运作的基础上 委员会由一名具有科学专业知识的高级研究员领导，致力于开发下一个 转化型乳腺癌研究人员的一代。多学科指导委员会将 由主要导师和辅助临床和/或基础研究者组成， 全面的指导计划加上一名统计员。它被认为是至关重要的获奖者的成功， 辅导工作应持续进行，并保持活力。这将在选委会主任的密切监督下完成 的辅导过程和获奖者的进展。Goetz博士，CEP主任和SPORE主任， 将向SPORE执行委员会报告。建立这一强化监督程序是因为 SPORE董事坚信，独立调查人员和翻译乳房的发展 癌症研究是孢子使命的核心。明确的期望是，获奖者将利用 为他们提供的资源，用于开发独立的研究计划和获取 独立资助乳腺癌研究。我们要求每年提供50 000美元（直接费用）， 这个戒酒会这这将由马约诊所癌症中心支助的50 000美元（直接费用）补充。一 每年将提供10万美元的奖励，可用于工资，技术支持和用品。一 获奖者将每年获得支持，给定的获奖者可以支持长达两年， 取得了令人满意的进展。迄今为止，CEP已成功地在10个获奖者中， 已成功竞争成为SPORE项目的联合领导人或 丹此外，一半是妇女（3人）或少数民族（2人）。此外，在这3名妇女中， 晋升为SPORE的领导职位，包括核心B联席董事和核心C联席董事。

PROJECT SUMMARY The Career Enhancement Program (CEP) of the Mayo Clinic Breast Cancer SPORE is committed to identifying and mentoring junior faculty with the greatest potential of developing independent programs in translational breast cancer research. This is accomplished through a rigorous review process aimed at identifying the most talented and promising candidates followed by an intensive, rigorous and effective mentoring program. The mentoring program is based on the establishment and optimal functioning of a Multidisciplinary Mentoring Committee led by a senior investigator with the scientific expertise and commitment to developing the next generation of translational breast cancer researchers. The Multidisciplinary Mentoring Committee will be composed of the primary mentor and the complementary clinical and/or basic investigator necessary for a comprehensive mentoring program plus a statistician. It is viewed as crucial to the success of the awardee that the mentoring be ongoing and robust. This will be accomplished by close oversight by the Director of the CEP of the mentoring process and progress of the awardee. Dr. Goetz, the Director of the CEP and SPORE Director, will report to the SPORE Executive Committee. This intensive oversight process was established because of the firm conviction of the SPORE Director that the development of independent investigators and translational breast cancer research is central to the SPORE mission. The explicit expectation is that the awardees will utilize the resources made available to them for the development of independent research programs and acquisition of independent funding in breast cancer research. We are requesting $50,000 per year (direct costs) to support this program. This will be supplemented by $50,000 (direct costs) of Mayo Clinic Cancer Center support. One award of $100,000 per year will be made, which can be used for salary, technician support, and supplies. One awardee will be supported per year and a given awardee can be supported for up to two years providing satisfactory progress is demonstrated. To date the CEP has been successful in that of the 10 awardees, five have successfully competed to become either SPORE Project Co-Leaders in full Projects or Co-Directors of Cores. Additionally, half have been women (three) or minority (two). Further, of the 3 women, 2 have been promoted into leadership positions in the SPORE including Core B Co-Director and Core C Co-Director.